ClinicalTrials.gov
ClinicalTrials.gov Menu

Open-Label Extension Trial to Characterize the Long-term Safety and Tolerability of Elamipretide in Subjects With Genetically Confirmed Primary Mitochondrial Myopathy (PMM)

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT02976038
Recruitment Status : Enrolling by invitation
First Posted : November 29, 2016
Last Update Posted : April 6, 2018
Sponsor:
Information provided by (Responsible Party):
Stealth BioTherapeutics Inc.

No Study Results Posted on ClinicalTrials.gov for this Study
  Recruitment Status : Enrolling by invitation
  Estimated Primary Completion Date : December 2021
  Estimated Study Completion Date : December 2021